Page last updated: 2024-11-13

saprisartan potassium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

saprisartan potassium: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID23678978
CHEMBL ID3989726
SCHEMBL ID588530
MeSH IDM0236861

Synonyms (18)

Synonym
saprisartan potassium
gr-138950c
146613-90-3
unii-t28707pg7t
1-((3-bromo-2-(o-(1,1,1-(trifluoromethanesulfonamido)phenyl)-5-benzofuranyl)methyl)-4-cyclopropyl-2-ethylimidazole-5-carboxamide, monopotassium salt
gr 138950c
1h-imidazole-5-carboxamide, 1-((3-bromo-2-(2-(((trifluoromethyl)sulfonyl)amino)phenyl-5-benzofuranyl)methyl)-4-cyclopropyl-2-ethyl-, monopotassium salt
1h-imidazole-5-carboxamide, 1-((3-bromo-2-(2-(((trifluoromethyl)sulfonyl)amino)phenyl)-5-benzofuranyl)methyl)-4-cyclopropyl-2-ethyl-, monopotassium salt
saprisartan potassium [usan]
t28707pg7t ,
SCHEMBL588530
1-[[3-bromo-2-[o-(1,1,1-(trifluoromethanesulfonamido)phenyl]-5-benzofuranyl]methyl]-4-cyclopropyl-2-ethylimidazole-5-carboxamide, monopotassium salt
saprisartan potassium [who-dd]
1-((3-bromo-2-(2-(((trifluoro-methyl)sulfonyl)amino)phenyl)-5-benzofuranyl)methyl)-4-cyclopropyl-2-ethyl-1h-imidazole-5-carboxamide potassium
DTXSID40163421
CHEMBL3989726
Q27289569
potassium;[2-[3-bromo-5-[(5-carbamoyl-4-cyclopropyl-2-ethylimidazol-1-yl)methyl]-1-benzofuran-2-yl]phenyl]-(trifluoromethylsulfonyl)azanide

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Using GR117289, a compound with moderate bioavailability (20%) in man as a lead, we pursued a strategy aimed at enhancing bioavailability."( Bromobenzofuran-based non-peptide antagonists of angiotensin II: GR138950, a potent antihypertensive agent with high oral bioavailability.
Dowle, MD; Hobson, JE; Jack, TI; Judd, DB; Middlemiss, D; Panchal, TA; Pass, M; Ross, BC; Scopes, DI; Tranquillini, E, 1994
)
0.29

Dosage Studied

ExcerptRelevanceReference
" Parallel displacements in AII dose-response curves occurred without any reduction in the maximum response to AII."( Pharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist.
Drew, GM; Hilditch, A; Hunt, AA; Judd, DB; Middlemiss, D; Polley, J; Robertson, MJ; Ross, BC; Travers, A, 1995
)
0.29
"5% chitosan G210) containing the drug were administered nasally to rats by inserting a dosing cannula 7mm into the nasal cavity after which the plasma and brain tissue levels were measured."( Nasal administration of an angiotensin antagonist in the rat model: effect of bioadhesive formulations on the distribution of drugs to the systemic and central nervous systems.
Charlton, ST; Davis, SS; Illum, L, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's14 (70.00)18.2507
2000's5 (25.00)29.6817
2010's1 (5.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.09 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.13 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]